AU
UK
CA
NZ
IND
US
Last update at 2026-06-10T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
ASX Stocks Estimated To Be Undervalued By Up To 30.4%
Wed 20 May 26, 07:34 PMAt AU$22.49, Is It Time To Put ALS Limited (ASX:ALQ) On Your Watch List?
Thu 09 Apr 26, 11:09 PMCalculating The Fair Value Of ALS Limited (ASX:ALQ)
Tue 21 Oct 25, 03:00 AMASX Stocks Estimated To Be Up To 48.2% Below Intrinsic Value
Tue 30 Sep 25, 07:34 PMAt AU$19.94, Is It Time To Put ALS Limited (ASX:ALQ) On Your Watch List?
Mon 22 Sep 25, 03:00 AM3 ASX Stocks That May Be Trading At Discounts Up To 41.8%
Mon 01 Sep 25, 07:34 PM3 ASX Stocks Estimated To Be 25.8% To 50% Below Their Intrinsic Value
Sun 03 Aug 25, 07:34 PMALS' (ASX:ALQ) investors will be pleased with their stellar 143% return over the last five years
Sun 27 Jul 25, 11:48 PM3 ASX Stocks Estimated To Be Trading Up To 40.9% Below Intrinsic Value
Mon 26 May 25, 07:34 PMAn Intrinsic Calculation For ALS Limited (ASX:ALQ) Suggests It's 25% Undervalued
Wed 14 May 25, 01:44 AM| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 362.70M | 121.30M | 390.70M | 282.40M | 248.50M |
| Minority interest | -2.70000M | -2.10000M | -1.30000M | -1.70000M | 10.80M |
| Net income | 256.20M | 12.90M | 291.20M | 190.50M | 172.60M |
| Selling general administrative | 1658.00M | 1308.50M | 1175.60M | 1123.90M | 986.70M |
| Selling and marketing expenses | - | 1171.30M | - | - | - |
| Gross profit | 2693.50M | 2194.90M | 2027.00M | 1880.70M | 1579.30M |
| Reconciled depreciation | 233.50M | 173.90M | 152.40M | 138.90M | 132.60M |
| Ebit | 483.50M | 179.90M | 434.50M | 324.30M | 288.40M |
| Ebitda | 615.80M | 353.80M | 586.90M | 463.20M | 421.00M |
| Depreciation and amortization | 132.30M | 173.90M | 152.40M | 138.90M | 132.60M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 424.50M | 401.80M | 434.50M | 324.30M | 288.40M |
| Other operating expenses | 2282.40M | 2059.80M | 1847.30M | 1790.10M | 1495.00M |
| Interest expense | 78.80M | 58.60M | 43.00M | 33.30M | 35.00M |
| Tax provision | 103.80M | 106.30M | 114.40M | 90.20M | 74.40M |
| Interest income | 10.00M | 10.50M | 5.40M | 1.40M | 2.20M |
| Net interest income | -82.70000M | -57.10000M | -45.30000M | -39.00000M | -32.80000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 103.80M | 106.30M | 114.40M | 90.20M | 74.40M |
| Total revenue | 2999.40M | 2461.60M | 2279.20M | 2108.50M | 1761.40M |
| Total operating expenses | 2269.00M | 1793.10M | 1595.10M | 1562.30M | 1312.90M |
| Cost of revenue | 305.90M | 266.70M | 252.20M | 227.80M | 182.10M |
| Total other income expense net | -61.80000M | -520.10000M | 4.10M | 3.00M | 22.10M |
| Discontinued operations | - | - | 16.20M | 0.60M | 0.60M |
| Net income from continuing ops | 258.90M | 15.00M | 276.30M | 192.20M | 174.10M |
| Net income applicable to common shares | - | - | 291.20M | 190.50M | 169.60M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 4062.20M | 3696.20M | 3330.10M | 2844.20M | 2476.90M |
| Intangible assets | 167.30M | 133.40M | 113.20M | 76.20M | 72.40M |
| Earning assets | - | - | - | - | - |
| Other current assets | 143.10M | 76.70M | 8.40M | 19.50M | 5.00M |
| Total liab | 2768.10M | 2499.30M | 1951.90M | 1713.50M | 1397.10M |
| Total stockholder equity | 1279.70M | 1183.30M | 1366.90M | 1120.10M | 1069.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 419.10M | 397.40M | 332.60M | 85.50M | 270.00M |
| Common stock | 1337.40M | 1325.90M | 1326.10M | 1321.00M | 1304.60M |
| Capital stock | 1337.40M | 1325.90M | 1326.10M | 1321.00M | 1304.60M |
| Retained earnings | -60.50000M | -129.40000M | 49.50M | -76.20000M | -104.50000M |
| Other liab | - | - | 70.40M | 79.60M | 107.10M |
| Good will | 1517.40M | 1376.60M | 1300.70M | 1118.60M | 1064.10M |
| Other assets | - | -44.50000M | 58.40M | 65.50M | 63.00M |
| Cash | 268.00M | 299.90M | 179.60M | 122.80M | 168.60M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 745.60M | 851.50M | 612.80M | 738.60M | 378.10M |
| Current deferred revenue | - | 0.50M | - | 67.20M | - |
| Net debt | 1825.10M | 1571.80M | 1268.60M | 1114.80M | 799.10M |
| Short term debt | 163.80M | 317.70M | 179.50M | 342.30M | 42.20M |
| Short long term debt | 74.60M | 239.60M | 128.30M | 299.70M | 5.00M |
| Short long term debt total | 2093.10M | 1871.70M | 1448.20M | 1237.60M | 967.70M |
| Other stockholder equity | - | - | -8.70000M | -124.70000M | -131.10000M |
| Property plant equipment | - | - | 812.50M | 693.40M | 631.30M |
| Total current assets | 1137.30M | 1028.00M | 753.30M | 641.90M | 611.10M |
| Long term investments | 36.60M | 46.10M | 293.50M | 250.80M | 35.00M |
| Net tangible assets | - | - | -47.00000M | -74.70000M | -92.30000M |
| Short term investments | - | 16.30M | - | 13.80M | - |
| Net receivables | 596.10M | 542.90M | 416.60M | 386.60M | 338.10M |
| Long term debt | 1617.50M | 1235.20M | 1074.30M | 895.30M | 777.20M |
| Inventory | 130.10M | 108.50M | 101.30M | 71.20M | 64.40M |
| Accounts payable | 162.70M | 122.10M | 100.70M | 310.80M | 65.90M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 2.80M | -13.20000M | -8.70000M | -124.70000M | -131.10000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 39.60M | 42.40M | 32.50M | 21.40M | 22.40M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2924.90M | 2668.20M | 2576.80M | 2202.30M | 1865.80M |
| Capital lease obligations | 401.00M | 396.90M | 245.60M | 342.30M | 185.50M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -327.70000M | -226.80000M | -267.00000M | -224.00000M | 2.60M |
| Change to liabilities | - | - | 23.30M | 50.10M | -36.60000M |
| Total cashflows from investing activities | -327.70000M | -226.80000M | -267.00000M | -405.90000M | -120.50000M |
| Net borrowings | 146.70M | 247.50M | 55.40M | 208.70M | -308.60000M |
| Total cash from financing activities | -120.00000M | -3.10000M | -121.20000M | 77.40M | -379.90000M |
| Change to operating activities | - | - | - | - | - |
| Net income | 256.20M | 12.90M | 291.20M | 190.50M | 169.60M |
| Change in cash | -31.90000M | 120.30M | 56.80M | -45.80000M | -255.30000M |
| Begin period cash flow | 299.90M | 179.60M | 122.80M | 168.60M | 423.90M |
| End period cash flow | 268.00M | 299.90M | 179.60M | 122.80M | 168.60M |
| Total cash from operating activities | 409.60M | 350.10M | 439.90M | 286.80M | 265.80M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | - | 173.90M | 152.50M | 134.70M | 128.60M |
| Other cashflows from investing activities | 8.70M | -13.90000M | 8.80M | 1.90M | 3.40M |
| Dividends paid | 177.10M | 188.80M | 176.60M | 131.30M | 71.30M |
| Change to inventory | -17.50000M | -1.80000M | -17.90000M | -6.80000M | 4.70M |
| Change to account receivables | -49.00000M | -42.90000M | -40.90000M | -55.90000M | -12.80000M |
| Sale purchase of stock | - | - | - | - | - |
| Other cashflows from financing activities | -89.60000M | -61.80000M | 587.80M | 362.60M | 371.20M |
| Change to netincome | - | - | 5.50M | -14.10000M | 2.90M |
| Capital expenditures | 165.00M | 151.70M | 146.10M | 118.90M | 81.10M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -66.50000M | -44.70000M | - | - | - |
| Stock based compensation | - | -6.40000M | - | - | - |
| Other non cash items | 476.10M | 394.80M | - | - | - |
| Free cash flow | 244.60M | 198.40M | -146.10000M | -118.90000M | -81.10000M |
Sector: Industrials Industry: Consulting Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CPBLF ALS Limited |
- -% | 16.11 | 35.90 | 21.83 | 2.51 | 5.90 | 4.04 | 18.18 |
| VRSK Verisk Analytics Inc |
-4.78 2.75% | 169.02 | 46.09 | 34.36 | 11.85 | 102.47 | 12.89 | 24.27 |
| EXPGF Experian PLC |
- -% | 33.42 | 26.59 | 19.34 | 4.43 | 6.44 | 4.99 | 14.01 |
| EXPGY Experian plc PK |
-0.12 0.36% | 32.98 | 26.45 | 19.30 | 4.41 | 6.43 | 4.99 | 14.01 |
| EFX Equifax Inc |
-0.655 0.43% | 153.28 | 33.88 | 23.31 | 3.82 | 5.20 | 4.75 | 15.73 |
ALS Limited engages in the provision of professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation services, tribology testing services, and related analytical testing. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
25 King Street, Brisbane, QLD, Australia, 4006
| Name | Title | Year Born |
|---|---|---|
| Mr. Raj Naran B.A., B.Sc. | MD, CEO & Exec. Director | 1963 |
| Mr. Luis Damasceno | Chief Financial Officer | NA |
| Mr. Bruce McDonald BSc.Hon(Geo), M.B.A (Hons), MSc(Geology) | Gen. Mang. of Geochemistry | NA |
| Ms. Kristen Walsh | Gen. Mang. of Industrial | NA |
| Tim Kilmister | Gen. Mang. of Life Sciences APAC | NA |
| Mr. Andreas Jonsson | Gen. Mang. of Life Sciences EMEA | NA |
| Mr. Michael Paul Pearson ACIS, BA, GAICD, L.L.B., LLB | Gen. Counsel & Company Sec. | NA |
| Ms. Susan Putters B Bus (Strategic Human resources management), MBA | Global Head of HR | NA |
| Mr. Michael Burcham B Sc, GradDip Env, Grad Cert RM,Grad Dip App, MRAC | Chief Risk Officer | NA |
| Mr. Greg Affleck B. Bus (Accounting), CPA | Group Financial Controller | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...